Evidence map›Paper›PMID 31675367›Full record

ArticlePloS one2019

Predicting atrial fibrillation in primary care using machine learning.

Nathan R Hill, Daniel Ayoubkhani, Phil McEwan, Daniel M Sugrue, Usman Farooqui, Steven Lister, Matthew Lumley, Ameet Bakhai, Alexander T Cohen, Mark O'Neill and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 5 pooled it
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 5 syntheses or guidelines pooled it, 144 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Systematic, randomized atrial fibrillation screening using detailed phenotyping with a risk prediction model combined with patch electrocardiogram in a Swedish population aged 65 years or older: the CONSIDERING-AF trial.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Trial
  7. Trial
  8. Article
  9. Article
  10. Observational
  11. A risk model to predict atrial fibrillation in diabetes using machine learning: The ACCORD study.American heart journal plus : cardiology research and practice · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Nathan R HillBristol-Myers Squibb Pharmaceutical Ltd, Uxbridge, United Kingdom.
Daniel AyoubkhaniHealth Economics and Outcomes Research Ltd, Cardiff, United Kingdom.
Phil McEwanHealth Economics and Outcomes Research Ltd, Cardiff, United Kingdom.
Daniel M SugrueHealth Economics and Outcomes Research Ltd, Cardiff, United Kingdom.
Usman FarooquiBristol-Myers Squibb Pharmaceutical Ltd, Uxbridge, United Kingdom.
Steven ListerBristol-Myers Squibb Pharmaceutical Ltd, Uxbridge, United Kingdom.ORCID 0000-0001-6899-007X
Matthew LumleyPfizer Ltd, Surrey, United Kingdom.
Ameet BakhaiDepartment of Cardiology, Royal Free Hospital, London, United Kingdom.
Alexander T CohenDepartment of Haematological Medicine, Guys and St Thomas' NHS Foundation Trust, King's College London, London, United Kingdom.
Mark O'NeillDivision of Cardiovascular Medicine, Guys and St Thomas' NHS Foundation Trust, King's College London, London, United Kingdom.
David CliftonDepartment of Engineering Science, University of Oxford, Oxford, United Kingdom.
Jason GordonHealth Economics and Outcomes Research Ltd, Cardiff, United Kingdom.
Health Economics and Outcomes Research (United Kingdom) · GBBristol-Myers Squibb (United Kingdom) · GBKing's College London · GBPfizer (United Kingdom) · GBThe Royal Free Hospital · GBUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAtrial fibrillation (AF) is the most common sustained heart arrhythmia. However, as many cases are asymptomatic, a large proportion of patients remain undiagnosed until serious complications arise. Efficient, cost-effective detection of the undiagnosed may be supported by risk-prediction models relating patient factors to AF risk. However, there exists a need for an implementable risk model that is contemporaneous and informed by routinely collected patient data, reflecting the real-world pathology of AF.

methodsThis study sought to develop and evaluate novel and conventional statistical and machine learning models for risk-predication of AF. This was a retrospective, cohort study of adults (aged ≥30 years) without a history of AF, listed on the Clinical Practice Research Datalink, from January 2006 to December 2016. Models evaluated included published risk models (Framingham, ARIC, CHARGE-AF), machine learning models, which evaluated baseline and time-updated information (neural network, LASSO, random forests, support vector machines), and Cox regression.

resultsAnalysis of 2,994,837 individuals (3.2% AF) identified time-varying neural networks as the optimal model achieving an AUROC of 0.827 vs. 0.725, with number needed to screen of 9 vs. 13 patients at 75% sensitivity, when compared with the best existing model CHARGE-AF. The optimal model confirmed known baseline risk factors (age, previous cardiovascular disease, antihypertensive medication usage) and identified additional time-varying predictors (proximity of cardiovascular events, body mass index (both levels and changes), pulse pressure, and the frequency of blood pressure measurements).

conclusionThe optimal time-varying machine learning model exhibited greater predictive performance than existing AF risk models and reflected known and new patient risk factors for AF.

Indexed as

Machine LearningAdultAgedAge FactorsAntihypertensive AgentsAtrial FibrillationBlood PressureBody Mass IndexCardiovascular DiseasesFemaleHumansMaleMiddle AgedNeural Networks, ComputerPrimary Health CareRetrospective StudiesAntihypertensive Agents

Identifiers

PMID31675367
PMCPMC6824570
OpenAlexW2987212315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.